Clinical trial Recruiting at 1 site Interventional Ages 9 to 22

A program to educate and support middle and high school students about substance use

Official title: A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students

Run by Massachusetts General Hospital · NCT06115746 · Data updated 2026-11-12

This study is testing a new drug education program for middle and high school students who have broken school rules about substance use to see if it helps them make better choices about drugs.

Quick facts

Study typeInterventional
Ages9 Years to 22 Years
SexAll
Enrollment300 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedNovember 17, 2023
Main results expectedJuly 31, 2028
Study endsJuly 31, 2028
Registry record updatedOctober 30, 2025
Trial IDNCT06115746 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are middle and high school students who have violated school substance use policies within the past month.

Probably not a fit

Patients who have previously received inpatient or specialty substance use treatment may not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of the iDECIDE curriculum, a novel drug education and diversion program, for middle and high school students who have recently violated school substance use policies. Approximately 300 participants will be randomly assigned to either the iDECIDE program or a waitlist control group, with the aim of improving their knowledge, attitudes, and behaviors regarding substance use. The program includes behavioral support and psychoeducation delivered through videoconference or in-person visits over a four-week period. Participants will be monitored for one year to assess the impact of the intervention on their substance use outcomes.

Why it matters

Potential benefit: If successful, this program could provide adolescents with the knowledge and skills to make healthier decisions regarding substance use, potentially reducing future substance-related issues.

How similar studies have gone: Other studies have shown success with similar educational and diversion programs for substance use, indicating potential for positive outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Currently enrolled in middle or high school;
2. Violated school substance use policy within approximately the past month at the time of screening;
3. Have a parent or legal guardian who is able and willing to provide written informed consent (if under the age of 18);
4. Competent and willing to provide written informed assent (if under the age of 18) or written informed consent (if age 18 or older);
5. Able to commit to 9 study visits over approximately one year;
6. Able to safely participate in the protocol and appropriate for outpatient level of care, in the opinion of the investigator;
7. Has access to a reliable internet connection and a device that can run Zoom;
8. Able to read and write comfortably in one of the languages spoken by study staff.

Exclusion Criteria:

1. Ever received substance use treatment in an inpatient or specialty care setting;
2. Ever engaged in intravenous (IV) drug use;
3. Current daily use of alcohol, non-medical benzodiazepines, and/or opioid use.

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.